HRPK20040328B3 - Pharmaceutical composition comprising gamma-butyrobetaine - Google Patents

Pharmaceutical composition comprising gamma-butyrobetaine

Info

Publication number
HRPK20040328B3
HRPK20040328B3 HR20040328A HRP20040328A HRPK20040328B3 HR PK20040328 B3 HRPK20040328 B3 HR PK20040328B3 HR 20040328 A HR20040328 A HR 20040328A HR P20040328 A HRP20040328 A HR P20040328A HR PK20040328 B3 HRPK20040328 B3 HR PK20040328B3
Authority
HR
Croatia
Prior art keywords
butyrobetaine
gamma
pharmaceutical composition
normalizing
potency
Prior art date
Application number
HR20040328A
Other languages
English (en)
Croatian (hr)
Inventor
Kalvinsh Ivars
Veveris Maris
Birmans Anatolijs
Original Assignee
Anatolijs Birmans Ivars Kalvinsh Maris Veveris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anatolijs Birmans Ivars Kalvinsh Maris Veveris filed Critical Anatolijs Birmans Ivars Kalvinsh Maris Veveris
Publication of HRP20040328A2 publication Critical patent/HRP20040328A2/hr
Publication of HRPK20040328B3 publication Critical patent/HRPK20040328B3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
HR20040328A 2001-09-07 2004-04-07 Pharmaceutical composition comprising gamma-butyrobetaine HRPK20040328B3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LVP-01-134A LV12979B (en) 2001-09-07 2001-09-07 Pharmaceutical composition
PCT/LV2002/000004 WO2003022262A1 (en) 2001-09-07 2002-03-04 Pharmaceutical composition comprising gamma-butyrobetaine

Publications (2)

Publication Number Publication Date
HRP20040328A2 HRP20040328A2 (en) 2004-08-31
HRPK20040328B3 true HRPK20040328B3 (en) 2006-02-28

Family

ID=19735292

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040328A HRPK20040328B3 (en) 2001-09-07 2004-04-07 Pharmaceutical composition comprising gamma-butyrobetaine

Country Status (30)

Country Link
US (1) US20040242590A1 (xx)
EP (1) EP1429753B1 (xx)
JP (1) JP4382480B2 (xx)
KR (1) KR100841035B1 (xx)
CN (1) CN1275595C (xx)
AR (1) AR036423A1 (xx)
AT (1) ATE350029T1 (xx)
AU (1) AU2002236340B2 (xx)
BG (1) BG108673A (xx)
CA (1) CA2459719C (xx)
CU (1) CU23347B6 (xx)
DE (1) DE60217369T2 (xx)
DK (1) DK1429753T3 (xx)
EA (1) EA006675B1 (xx)
ES (1) ES2280505T3 (xx)
HK (1) HK1068003A1 (xx)
HR (1) HRPK20040328B3 (xx)
IL (2) IL160734A0 (xx)
JO (1) JO2507B1 (xx)
LV (1) LV12979B (xx)
MA (1) MA27683A1 (xx)
MX (1) MXPA04002050A (xx)
MY (1) MY134074A (xx)
NZ (1) NZ532178A (xx)
PL (1) PL368758A1 (xx)
PT (1) PT1429753E (xx)
SI (1) SI1429753T1 (xx)
TW (1) TWI224506B (xx)
WO (1) WO2003022262A1 (xx)
ZA (1) ZA200402702B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10325813B4 (de) * 2003-06-06 2007-12-20 Universitätsklinikum Freiburg Prophylaxe und/oder Therapie bei der portalen Hypertonie
LV13450B (en) * 2004-08-24 2006-11-20 Grindeks As Novel medicinal use of meldonium and pharmaceutical compositions thereof
WO2007016361A2 (en) 2005-07-29 2007-02-08 Concert Pharmaceuticals Inc. Novel pharmaceutical compounds
WO2009095445A1 (en) * 2008-01-29 2009-08-06 Grindeks New second medical use of 3-(2,2,2-trimethylhydrazine)propionate dihydrate
CN101781302B (zh) * 2009-05-31 2013-07-10 段波 一种磷酸二酯酶抑制剂和异黄酮形成的加成物及其应用
RU2622757C1 (ru) * 2016-06-02 2017-06-19 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ лечения эректильной дисфункции

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1198434B (it) * 1981-01-06 1988-12-21 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
LV11728B (en) 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition

Also Published As

Publication number Publication date
IL160734A (en) 2009-09-22
DE60217369D1 (de) 2007-02-15
DE60217369T2 (de) 2007-08-23
LV12979B (en) 2003-05-20
EA006675B1 (ru) 2006-02-24
TWI224506B (en) 2004-12-01
MA27683A1 (fr) 2006-01-02
MY134074A (en) 2007-11-30
CU23347B6 (es) 2009-02-20
KR100841035B1 (ko) 2008-06-24
EP1429753B1 (en) 2007-01-03
CA2459719A1 (en) 2003-03-20
EP1429753A1 (en) 2004-06-23
EA200400386A1 (ru) 2004-08-26
CN1551764A (zh) 2004-12-01
HK1068003A1 (en) 2005-04-22
PL368758A1 (en) 2005-04-04
ZA200402702B (en) 2005-05-11
SI1429753T1 (sl) 2007-06-30
ES2280505T3 (es) 2007-09-16
JO2507B1 (en) 2009-10-05
CA2459719C (en) 2010-07-06
KR20040034704A (ko) 2004-04-28
DK1429753T3 (da) 2007-05-14
AU2002236340B2 (en) 2008-06-12
PT1429753E (pt) 2007-04-30
MXPA04002050A (es) 2004-06-07
HRP20040328A2 (en) 2004-08-31
JP2005504071A (ja) 2005-02-10
IL160734A0 (en) 2004-08-31
WO2003022262A1 (en) 2003-03-20
US20040242590A1 (en) 2004-12-02
BG108673A (en) 2005-03-31
NZ532178A (en) 2007-05-31
JP4382480B2 (ja) 2009-12-16
ATE350029T1 (de) 2007-01-15
CN1275595C (zh) 2006-09-20
AR036423A1 (es) 2004-09-08

Similar Documents

Publication Publication Date Title
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
BR0208636A (pt) Agente terapêutico para doenças de artrìtides crÈnicas de doenças relacionadas com inf‰ncia
RS51961B (en) APPLICATION OF FLIBANSERINE FOR TREATMENT OF SEXUAL DESIRE DISORDERS IN PREMENOPAUSE
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
DK1178958T3 (da) N-cyanomethylamider som proteaseinhibitorer
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
DK1296671T3 (da) Gabapentinanaloger til sövnforstyrrelser
SE9900961D0 (sv) Novel compounds
SE0102036D0 (sv) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
EA200501690A1 (ru) Композиция, включающая ингибитор pde4 и ингибитор pde5
AR034343A1 (es) Combinaciones farmaceuticas
SE9802208D0 (sv) Novel compounds
NO20024646D0 (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
SE0102440D0 (sv) New compound
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
NO20051261L (no) Morfin-6-glukuronidsalt
HRPK20040328B3 (en) Pharmaceutical composition comprising gamma-butyrobetaine
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
SE9802209D0 (sv) Novel compounds
SE0001916D0 (sv) Novel formulation

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AKOB Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent)
PKB1 Consensual patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20100831

Year of fee payment: 9

PBKO Lapse due to non-payment of renewal fee for consensual patent

Effective date: 20110305